Laparoscopic anti-reflux surgery is effective in obese patients with gastro-oesophageal reflux disease

Annals of the Royal College of Surgeons of England

Volumn 89, Issue 7, 2007, Pages 696-702

  Ng, Vivien V ^a   Booth, Michael I ^a   Stratford, Jane J ^a   Jones, Linda ^a   Sohanpal, J ^a   Dehn, Thomas C B ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

GORD; Laparoscopic anti reflux surgery; Obesity

Indexed keywords

ANTACID AGENT; STOMACH SECRETION INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; BLEEDING; BODY MASS; COLON PERFORATION; COLON VOLVULUS; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS DILATATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEMICOLECTOMY; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBESITY; OPERATION DURATION; PATIENT SATISFACTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REOPERATION; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STOMACH PH; THERAPY EFFECT; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHILD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 35348878000     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588407X205323     Document Type: Article

References (20)

1. Locke 3rd GR, Talley NJ, Fett SL, Zinsmeister AR, Melton 3rd LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642-9.
2. Wajed SA, Streets CG, Bremner CG, DeMeester TR. Elevated body mass disrupts the barrier to gastroesophageai reflux. Arch Surg 2001; 136: 1014-8, discussion 1018-9.
3. Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD. Gastro-esophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev 2002; 3: 9-15.
4. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001; 15: 986-9.
5. Beauchamp G. Gastroesophageal reflux and obesity. Surg Clin North Am 1983; 63: 869-76.
6. Fraser J, Watson DI, O'Boyle CJ, Jamieson GC. Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esophagus 2001; 14: 50-3.
7. Winslow ER, Frisella MM, Soper NJ, Klingensmith ME. Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 2003; 17: 2003-11.
8. Hahnloser D, Schumacher M, Cavin R, Cosendey B, Petropoulos P. Risk factors for complications of laparoscopic Nissen fundoplication. Surg Endosc 2002; 16: 43-7.
9. Booth MI, Jones L, Stratford JJ, Dehn TCB. Results of laparoscopic Nissen fundoplication at 2-8 years after surgery. Br J Surg 2002; 89: 476-81.
10. Kellogg TA, Oelschlager BK, Pellegrini CA. Laparoscopic antireflux surgery. VHJOE 2003; 2: 2-3-3.
11. Lundell L, Abrahamsson H, Ruth M, Rydberg L, Lonroth H, Olbe L. Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg 1996; 83: 830-5.
12. Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994; 220: 472-81.
13. Peters JH, DeMeester TR, Crookes PF, Öberg S, de Voss Shoop M, Hagen JA et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication., prospective evaluation of 100 patients with 'typical' symptoms. Ann Surg 1998; 228: 40-50.
14. Campos GMR, Peters JH, DeMeester TR., Öberg S, Crookes PF, Tan S et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
15. Gordon C, Kang JY, Neild PJ, Maxwell JD. The role of the hiatus hernia in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20: 719.
16. Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002; 16: 1027-31.
17. Smith SC, Edwards CB, Goodman GN. Symptomatic improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg 1997; 7: 479-84.
18. Raftopoulos I, Awais O, Courcoulas AP, Luketich JD. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg 2004; 14: 1373-80.
19. Smith CD, McClusky DA, Rajad MA, Lederman AB, Hunter JG. When fundoplication fails: redo? Ann Surg 2005; 241: 861-9.
20. Patterson EJ, Davis DG, Khajanchee Y, Swanström LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc 2003; 17: 1561-5.